Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly

synapdx-press-release-autism-investment-conference-participation-updated-final-2-21-13Download Image promoting 2014 Autism Investment Conference by Autism Speaks March 4-5 2014. FOR IMMEDIATE RELEASE SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference Discusses Diagnostic Issues at Event Hosted by Autism Speaks Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present …

Archived | Lexington’s SynapDx gets $2m as it looks to develop new autism test & Press Releases | Circa February 21, 2013 #NotAnAutisticAlly AGRE Collection

SynapDx logo Lexington’s SynapDx gets $2m as it looks to develop new autism test By Chris Reidy | Boston.com SynapDx Corp., a Lexington firm developing diagnostics for the earlier detection of autism, said Thursday that it has gotten $2 million in funding from Laboratory Corporation of America Holdings, or LabCorp, a North Carolina-based company that specializes …

Archived | Autism Speaks: Autism Treatment Network | Circa 2007 #NotAnAutisticAlly

Image: Human head and shoulders silhouette with Not An Autistic Ally text and the logo for Autism Speaks Autism Treatment Network (ATN). Interactive autism network (ian) Autism Treatment Network (ATN) Autism INtervention Research Network on Physical Health Autism Treatment Network What is the ATN?  The Autism Treatment Network (ATN) is a network of treatment and …

Archived | Autism Speaks: Clinical Trials Network | Circa 2007 #NotAnAutisticAlly

Clinical Trials Network Fluoxetine StudyMemantine Study Autism Speaks' Clinical Trials Network (CTN) was officially launched in 2005 by Cure Autism Now to focus on translational research, the critical step necessary to transfer findings from the laboratory to clinical application. Well controlled and appropriately blinded studies are needed to test whether anecdotal evidence holds. By facilitating …

Archived | Autism Speaks: New Developments In Autism Clinical Trials | Circa January 2004 #NotAnAutisticAlly

Download PDF d_200707_CANCONSENSUSDownload Jump to: New Developments in Autism Clinical Trials Outcome Measures for Clinical Drug Trials in Autism Subject Selection and Characterization in Clinical Trials in Children with Autism Impact of Recent Findings on Study Design of Future Autism Clinical Trials Autism Clinical Trials: Biological and Medical Issues in Patient Selection and Treatment Response …

Archived | Cure Autism Now: Autism Screening & Diagnostic Evaluation: CAN Consensus Statement | Circa March 1998 #NotAnAutisticAlly

Screenshot of the newsletter front page. d_200707_canconsensusDownload Feature Article CNS Spectrums Journal March 1998 Published in the CNS Spectrums Journal Volume 3 -Number 3 • March 1998 Autism Screening and Diagnostic Evaluation: CAN Consensus Statement EDUCATIONAL OBJECTIVES Discuss the usefulness of a simple screening tool for autism and pervasive developmental disorders.Identify appropriate neurodevelopmental evaluations in …

Archived | Autism Speaks: Brain Development Initiative | Circa 2007 #NotAnAutisticAlly

Screenshot of Brain Development Initiative page Portfolio: Autism Biology The biology of autism is the focus of one of four primary portfolios in the Autism Speaks Sciences Program. The Biology Portfolio will focus on the areas of neuroscience, physiology and molecular biology to gain a better understanding of the pathology and underlying biological mechanisms that …